Couchbase Inc has a consensus price target of $26.69, established from looking at the 88 latest analyst ratings. The last 3 analyst ratings were released from Needham, Guggenheim, and DA Davidson on June 26, 2024, June 25, 2024, and June 7, 2024. With an average price target of $27.33 between Needham, Guggenheim, and DA Davidson, there's an implied 51.94% upside for Couchbase Inc from these 3 analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
06/26/2024 | Buy Now | 22.29% | Needham | Mike Cikos | → $22 | Initiates | → Buy | Get Alert |
06/25/2024 | Buy Now | 66.76% | Guggenheim | Howard Ma | $30 → $30 | Reiterates | Buy → Buy | Get Alert |
06/07/2024 | Buy Now | 66.76% | DA Davidson | Rudy Kessinger | $35 → $30 | Maintains | Buy | Get Alert |
06/06/2024 | Buy Now | 66.76% | Wells Fargo | Andrew Nowinski | $37 → $30 | Maintains | Overweight | Get Alert |
06/06/2024 | Buy Now | 50.08% | Barclays | Raimo Lenschow | $33 → $27 | Maintains | Equal-Weight | Get Alert |
06/06/2024 | Buy Now | 66.76% | Oppenheimer | Ittai Kidron | $36 → $30 | Maintains | Outperform | Get Alert |
06/06/2024 | Buy Now | 61.2% | Morgan Stanley | Sanjit Singh | $30 → $29 | Maintains | Equal-Weight | Get Alert |
06/06/2024 | Buy Now | 0.06% | Goldman Sachs | Kash Rangan | $30 → $18 | Downgrade | Neutral → Sell | Get Alert |
06/06/2024 | Buy Now | 77.88% | Baird | Rob Oliver | $35 → $32 | Maintains | Outperform | Get Alert |
06/06/2024 | Buy Now | 72.32% | RBC Capital | Matthew Hedberg | $35 → $31 | Maintains | Outperform | Get Alert |
05/22/2024 | Buy Now | 72.32% | UBS | Austin Dietz | → $31 | Initiates | → Neutral | Get Alert |
03/07/2024 | Buy Now | 66.76% | Goldman Sachs | Kash Rangan | $20 → $30 | Maintains | Neutral | Get Alert |
03/06/2024 | Buy Now | 94.55% | DA Davidson | Rudy Kessinger | $27 → $35 | Maintains | Buy | Get Alert |
03/06/2024 | Buy Now | 83.44% | Stifel | Brad Reback | $24 → $33 | Maintains | Buy | Get Alert |
03/06/2024 | Buy Now | 94.55% | RBC Capital | Matthew Hedberg | $32 → $35 | Maintains | Outperform | Get Alert |
03/06/2024 | Buy Now | 100.11% | Oppenheimer | Ittai Kidron | $25 → $36 | Maintains | Outperform | Get Alert |
03/06/2024 | Buy Now | 94.55% | Baird | Rob Oliver | $28 → $35 | Maintains | Outperform | Get Alert |
03/06/2024 | Buy Now | 83.44% | Barclays | Raimo Lenschow | $29 → $33 | Maintains | Equal-Weight | Get Alert |
03/06/2024 | Buy Now | 77.88% | Guggenheim | Howard Ma | $27 → $32 | Maintains | Buy | Get Alert |
03/06/2024 | Buy Now | 105.67% | Wells Fargo | Andrew Nowinski | $34 → $37 | Maintains | Overweight | Get Alert |
03/05/2024 | Buy Now | 88.99% | Wells Fargo | Andrew Nowinski | $26 → $34 | Maintains | Overweight | Get Alert |
02/20/2024 | Buy Now | 61.2% | Barclays | Raimo Lenschow | $26 → $29 | Downgrade | Overweight → Equal-Weight | Get Alert |
01/12/2024 | Buy Now | 44.52% | Barclays | Raimo Lenschow | $23 → $26 | Maintains | Overweight | Get Alert |
12/14/2023 | Buy Now | 44.52% | RBC Capital | Matthew Hedberg | → $26 | Reiterates | Outperform → Outperform | Get Alert |
12/11/2023 | Buy Now | 27.85% | Barclays | Raimo Lenschow | $21 → $23 | Maintains | Overweight | Get Alert |
12/07/2023 | Buy Now | 33.41% | Stifel | Brad Reback | $22 → $24 | Maintains | Buy | Get Alert |
12/07/2023 | Buy Now | 44.52% | RBC Capital | Matthew Hedberg | $25 → $26 | Maintains | Outperform | Get Alert |
12/07/2023 | Buy Now | 16.73% | Morgan Stanley | Sanjit Singh | $20 → $21 | Maintains | Equal-Weight | Get Alert |
09/13/2023 | Buy Now | 38.97% | RBC Capital | Matthew Hedberg | → $25 | Reiterates | Outperform → Outperform | Get Alert |
09/07/2023 | Buy Now | 38.97% | RBC Capital | Matthew Hedberg | → $25 | Reiterates | Outperform → Outperform | Get Alert |
08/18/2023 | Buy Now | 11.17% | Barclays | Raimo Lenschow | $23 → $20 | Maintains | Overweight | Get Alert |
06/07/2023 | Buy Now | 11.17% | Oppenheimer | Ittai Kidron | → $20 | Reiterates | Outperform → Outperform | Get Alert |
06/07/2023 | Buy Now | 11.17% | Morgan Stanley | Sanjit Singh | $19 → $20 | Maintains | Equal-Weight | Get Alert |
06/07/2023 | Buy Now | 38.97% | RBC Capital | Matthew Hedberg | → $25 | Reiterates | Outperform → Outperform | Get Alert |
06/07/2023 | Buy Now | -11.06% | Wedbush | Taz Koujalgi | → $16 | Reiterates | Neutral → Neutral | Get Alert |
06/07/2023 | Buy Now | 22.29% | Stifel | Brad Reback | $19 → $22 | Maintains | Buy | Get Alert |
06/07/2023 | Buy Now | 27.85% | Baird | Rob Oliver | $20 → $23 | Maintains | Outperform | Get Alert |
06/07/2023 | Buy Now | 27.85% | Barclays | Raimo Lenschow | $19 → $23 | Maintains | Overweight | Get Alert |
06/05/2023 | Buy Now | 38.97% | RBC Capital | Matthew Hedberg | $20 → $25 | Maintains | Outperform | Get Alert |
03/08/2023 | Buy Now | 5.61% | Stifel | Brad Reback | $17 → $19 | Maintains | Buy | Get Alert |
03/08/2023 | Buy Now | 11.17% | Baird | Rob Oliver | $18 → $20 | Maintains | Outperform | Get Alert |
03/08/2023 | Buy Now | 11.17% | Guggenheim | Howard Ma | → $20 | Reiterates | → Buy | Get Alert |
03/08/2023 | Buy Now | 5.61% | Morgan Stanley | Sanjit Singh | $18 → $19 | Maintains | Equal-Weight | Get Alert |
03/08/2023 | Buy Now | 11.17% | RBC Capital | Matthew Hedberg | $18 → $20 | Maintains | Outperform | Get Alert |
02/15/2023 | Buy Now | 5.61% | Barclays | Raimo Lenschow | $16 → $19 | Maintains | Overweight | Get Alert |
01/27/2023 | Buy Now | 11.17% | Guggenheim | Howard Ma | → $20 | Initiates | → Buy | Get Alert |
01/10/2023 | Buy Now | -11.06% | Barclays | Raimo Lenschow | $18 → $16 | Maintains | Overweight | Get Alert |
12/15/2022 | Buy Now | -11.06% | Wedbush | Taz Koujalgi | → $16 | Initiates | → Neutral | Get Alert |
12/07/2022 | Buy Now | 0.06% | Goldman Sachs | Kash Rangan | $20 → $18 | Maintains | Neutral | Get Alert |
12/07/2022 | Buy Now | 0.06% | RBC Capital | Matthew Hedberg | $20 → $18 | Maintains | Outperform | Get Alert |
12/07/2022 | Buy Now | 0.06% | Barclays | Raimo Lenschow | $17 → $18 | Maintains | Overweight | Get Alert |
11/21/2022 | Buy Now | 0.06% | Morgan Stanley | Sanjit Singh | $19 → $18 | Maintains | Equal-Weight | Get Alert |
11/18/2022 | Buy Now | -5.5% | Barclays | Raimo Lenschow | $20 → $17 | Maintains | Overweight | Get Alert |
10/18/2022 | Buy Now | 11.17% | Barclays | Raimo Lenschow | $22 → $20 | Maintains | Overweight | Get Alert |
09/08/2022 | Buy Now | 5.61% | Morgan Stanley | Sanjit Singh | $18 → $19 | Maintains | Equal-Weight | Get Alert |
09/08/2022 | Buy Now | 22.29% | Baird | Rob Oliver | $25 → $22 | Maintains | Outperform | Get Alert |
09/08/2022 | Buy Now | 22.29% | Barclays | Raimo Lenschow | $23 → $22 | Maintains | Overweight | Get Alert |
08/16/2022 | Buy Now | 27.85% | Barclays | Raimo Lenschow | $19 → $23 | Maintains | Overweight | Get Alert |
06/15/2022 | Buy Now | 16.73% | DA Davidson | Rudy Kessinger | → $21 | Initiates | → Buy | Get Alert |
06/10/2022 | Buy Now | 38.97% | Baird | Rob Oliver | $35 → $25 | Maintains | Outperform | Get Alert |
06/09/2022 | Buy Now | 11.17% | Stifel | Brad Reback | $25 → $20 | Maintains | Buy | Get Alert |
06/09/2022 | Buy Now | 0.06% | Morgan Stanley | Sanjit Singh | $17 → $18 | Maintains | Equal-Weight | Get Alert |
06/09/2022 | Buy Now | 22.29% | Oppenheimer | Ittai Kidron | $25 → $22 | Maintains | Outperform | Get Alert |
06/09/2022 | Buy Now | 38.97% | Goldman Sachs | Kash Rangan | $28 → $25 | Maintains | Neutral | Get Alert |
06/06/2022 | Buy Now | 38.97% | RBC Capital | Matthew Hedberg | $27 → $25 | Maintains | Outperform | Get Alert |
05/20/2022 | Buy Now | 5.61% | Barclays | David Strauss | $26 → $19 | Maintains | Overweight | Get Alert |
05/19/2022 | Buy Now | -5.5% | Morgan Stanley | Sanjit Singh | $22 → $17 | Maintains | Equal-Weight | Get Alert |
04/14/2022 | Buy Now | 55.64% | Goldman Sachs | Kash Rangan | $37 → $28 | Maintains | Neutral | Get Alert |
03/10/2022 | Buy Now | 44.52% | Barclays | Raimo Lenschow | $30 → $26 | Maintains | Overweight | Get Alert |
03/10/2022 | Buy Now | 38.97% | Stifel | Brad Reback | $41 → $25 | Maintains | Buy | Get Alert |
03/10/2022 | Buy Now | 22.29% | Morgan Stanley | Sanjit Singh | $24 → $22 | Maintains | Equal-Weight | Get Alert |
03/10/2022 | Buy Now | 50.08% | RBC Capital | Matthew Hedberg | $29 → $27 | Maintains | Outperform | Get Alert |
02/23/2022 | Buy Now | 33.41% | Morgan Stanley | Sanjit Singh | $37 → $24 | Maintains | Equal-Weight | Get Alert |
01/12/2022 | Buy Now | 66.76% | Barclays | Raimo Lenschow | $41 → $30 | Maintains | Overweight | Get Alert |
12/09/2021 | Buy Now | 133.46% | Goldman Sachs | Kash Rangan | — | Maintains | Neutral | Get Alert |
12/08/2021 | Buy Now | 177.93% | Oppenheimer | Ittai Kidron | — | Maintains | Outperform | Get Alert |
12/08/2021 | Buy Now | 133.46% | Goldman Sachs | Kash Rangan | — | Maintains | Neutral | Get Alert |
12/08/2021 | Buy Now | 127.9% | Barclays | Raimo Lenschow | — | Maintains | Overweight | Get Alert |
09/09/2021 | Buy Now | 105.67% | Morgan Stanley | Sanjit Singh | — | Maintains | Equal-Weight | Get Alert |
09/09/2021 | Buy Now | 200.17% | Barclays | Raimo Lenschow | — | Maintains | Overweight | Get Alert |
09/09/2021 | Buy Now | 177.93% | Oppenheimer | Ittai Kidron | — | Maintains | Outperform | Get Alert |
08/16/2021 | Buy Now | — | William Blair | Jason Ader | — | Initiates | → Outperform | Get Alert |
08/16/2021 | Buy Now | 88.99% | Morgan Stanley | Sanjit Singh | — | Initiates | → Equal-Weight | Get Alert |
08/16/2021 | Buy Now | 139.02% | Stifel | Brad Reback | — | Initiates | → Buy | Get Alert |
08/16/2021 | Buy Now | 172.37% | Goldman Sachs | — | — | Initiates | → Neutral | Get Alert |
08/16/2021 | Buy Now | 122.35% | RBC Capital | Matthew Hedberg | — | Initiates | → Outperform | Get Alert |
08/16/2021 | Buy Now | 139.02% | Baird | Rob Oliver | — | Initiates | → Outperform | Get Alert |
08/16/2021 | Buy Now | 133.46% | Barclays | Raimo Lenschow | — | Initiates | → Overweight | Get Alert |
The latest price target for Couchbase (NASDAQ:BASE) was reported by Needham on June 26, 2024. The analyst firm set a price target for $22.00 expecting BASE to rise to within 12 months (a possible 22.29% upside). 31 analyst firms have reported ratings in the last year.
The latest analyst rating for Couchbase (NASDAQ:BASE) was provided by Needham, and Couchbase initiated their buy rating.
There is no last upgrade for Couchbase
The last downgrade for Couchbase Inc happened on June 6, 2024 when Goldman Sachs changed their price target from $30 to $18 for Couchbase Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Couchbase, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Couchbase was filed on June 26, 2024 so you should expect the next rating to be made available sometime around June 26, 2025.
While ratings are subjective and will change, the latest Couchbase (BASE) rating was a initiated with a price target of $0.00 to $22.00. The current price Couchbase (BASE) is trading at is $17.99, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.